Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019Emma Nichols, Vera Marisa Costa, Jaimie D Steinmetz et al.|The Lancet Public Health|2022Cited by 5.1k
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease StudyRupert Bourne, Joshua R. Ehrlich, Akshaya Srikanth Bhagavathula et al.|The Lancet Global Health|2020Cited by 1.3k
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021Azalea Thomson, Deepa Dongarwar, Theresa A. McHugh et al.|The Lancet Haematology|2023Cited by 674
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysisTomislav Meštrović, Alexander G. Mathioudakis, Mohsen Naghavi et al.|The Lancet Public Health|2022Cited by 350
Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021Marita Cross, Ejaz Ahmad Khan, Kanyin Liane Ong et al.|The Lancet Rheumatology|2024Cited by 210